OB/GYN and Women's Health - Global Oncology Academy

Episodes 1-16 of 77

Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
Project Oncology®
Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
- Pavani Chalasani, MD, MPH
- Erica L. Mayer, MD, MPH
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
Project Oncology®
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
- Pavani Chalasani, MD, MPH
- Erica L. Mayer, MD, MPH
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
- Casey Cosgrove, MD
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Project Oncology®
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
- Brian Slomovitz, MD
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Project Oncology®
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
- Brian Slomovitz, MD
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Project Oncology®
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
- Ryan Quigley
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Project Oncology®
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
- Ryan Quigley
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
Project Oncology®
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
- Casey Cosgrove, MD
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Project Oncology®
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
Project Oncology®
Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Project Oncology®
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Project Oncology®
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Project Oncology®
Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
- Pavani Chalasani, MD, MPH
- Antonio Giordano, MD, PhD
Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
Project Oncology®
Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
- Charles Turck, PharmD, BCPS, BCCCP
- Virginia Kaklamani, MD
Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
Project Oncology®
Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
- Jennifer Caudle, DO
- Hope S. Rugo, MD, FASCO
Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
Advances in Women's Health
Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
- Ann Klopp, M.D., Ph.D.

Prev
1
2
3
4
5
Next

1/5